D R Murdoch

Summary

Affiliation: University of Glasgow
Country: UK

Publications

  1. pmc Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
    D R Murdoch
    Department of Cardiology, Western Infirmary, Dumbarton Road, Glasgow G11 6NT, UK
    Heart 82:352-6. 1999
  2. ncbi request reprint Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
    D R Murdoch
    Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, Scotland
    Am Heart J 138:1126-32. 1999
  3. ncbi request reprint ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects
    D R Murdoch
    Department of Cardiology, Western Infirmary, Glasgow, UK
    Am Heart J 141:800-7. 2001
  4. pmc Randomised controlled trial of specialist nurse intervention in heart failure
    L Blue
    Department of Cardiology, Western Infirmary, Dumbarton Road, Glasgow G12 6NT
    BMJ 323:715-8. 2001
  5. ncbi request reprint Economics of chronic heart failure
    C Berry
    MRC, Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, G12 8QQ, Glasgow, UK
    Eur J Heart Fail 3:283-91. 2001

Collaborators

Detail Information

Publications5

  1. pmc Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
    D R Murdoch
    Department of Cardiology, Western Infirmary, Dumbarton Road, Glasgow G11 6NT, UK
    Heart 82:352-6. 1999
    ..TNFalpha increases secretion of leptin, a hormone which decreases food intake and increases energy expenditure...
  2. ncbi request reprint Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
    D R Murdoch
    Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, Scotland
    Am Heart J 138:1126-32. 1999
    ..We sought to determine whether titration of vasodilator therapy according to plasma brain natriuretic peptide (BNP) concentration may be of value in the individual optimization of vasodilator therapy in CHF...
  3. ncbi request reprint ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects
    D R Murdoch
    Department of Cardiology, Western Infirmary, Glasgow, UK
    Am Heart J 141:800-7. 2001
    ..When added to ACE inhibitors, angiotensin II type 1 (AT1) antagonists may allow more complete blockade of the RAAS and preserve the beneficial effects of bradykinin accumulation not seen with AT1 receptor blockade alone...
  4. pmc Randomised controlled trial of specialist nurse intervention in heart failure
    L Blue
    Department of Cardiology, Western Infirmary, Dumbarton Road, Glasgow G12 6NT
    BMJ 323:715-8. 2001
    ..001) and spent fewer days in hospital for heart failure (mean 3.43 v 7.46 days, P=0.0051). CONCLUSIONS: Specially trained nurses can improve the outcome of patients admitted to hospital with heart failure...
  5. ncbi request reprint Economics of chronic heart failure
    C Berry
    MRC, Clinical Research Initiative in Heart Failure, West Medical Building, University of Glasgow, G12 8QQ, Glasgow, UK
    Eur J Heart Fail 3:283-91. 2001
    ..Optimization of drug therapy represents the most effective way of reducing costs. Recent economic analyses in the Netherlands and Sweden suggest the costs of care are rising...